Clinical Trials Logo

Survival Rate clinical trials

View clinical trials related to Survival Rate.

Filter by:
  • None
  • Page 1

NCT ID: NCT06252337 Recruiting - Periapical Diseases Clinical Trials

Survival and Success of Two Different Filling Techniques

ROOTCANAL
Start date: January 1, 2023
Phase: N/A
Study type: Interventional

This randomized clinical study analysed the clinical use of a new bioceramic premixed CaSi-containing sealer in association with a warm carrier-based technique or a traditional epoxy resin based sealer. Methodology: Healthy patients requiring root canal treatments were enrolled. Periapical X-rays were taken preoperatively, after root canal filling and after 1, 6, and 12 and 24 months. Two evaluators assessed the Periapical Index (PAI) and the sealer extrusion. The healing rate and survival rate were also evaluated. Barnard test was used to assess the relationship of each potential prognostic factor with periapical index (PAI) at 12-month follow-up. The significance level was set at 0.05.

NCT ID: NCT06095843 Completed - Survival Rate Clinical Trials

"Bony Changes Around Dental Implant in Free Fibular Graft Versus Non-Vascularized Iliac Crest Graft"

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the bony changes around dental implants in non-vascularized iliac crest grafts and free vascularized fibular flap in mandibular reconstruction. The main question it aims to answer are: • evaluate the bony changes around dental implants and it's survival rate in both groups

NCT ID: NCT04396080 Recruiting - Clinical trials for Clinical Performance

Prospective Clinical Trial of Onlay-carrying Patients

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

A record of the type of onlay will be made with respect to its extension, tooth or teeth to be treated, the material of clothing and the substrate on which the adhesion and cementing method, as well as the type of antagonist. To complete it, a complete clinical oral examination will be performed with oral mirrors, examination probes, joint paper, disposable gloves, masks, paper napkins, plastic cups, dental equipment lighting lamp, cold spray , photogrammed camera, including an intraoral scan to have a 3D file of the patient's condition on the day of embedding placement. Once treatment is complete, the patient should go to routine check-ups in which a full intraoral exploration and data collection intended to be carried out analyze the following variables (USPHS modificated): possible decemented and fractured, decay and marginal integrity, sensitivity or loss of vitality, as well as the degree of patient satisfaction (VAS).

NCT ID: NCT03193710 Recruiting - Clinical trials for Colorectal Cancer Metastatic

The Effects of General Anesthetics on Lymphocytes in Patients Undergoing Colorectal Cancer Resection and Mechanism Involved

Start date: September 1, 2017
Phase: N/A
Study type: Observational

The body immunity is important to the development of tumor. The immune system is in charge of monitoring and cleaning tumor cells in circulation. Anesthesia may alter the immune response and affect the elimination of tumor cells. The purpose of the trial is to test whether inhalational anesthetic is relevant to tumor metastasis and recurrence of patients undergoing colorectal cancer resection through depression of lymphocytes-mediated immunity.

NCT ID: NCT03191123 Recruiting - Clinical trials for Carcinoma, Hepatocellular

Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma With Solitary Huge Tumor

Start date: July 5, 2016
Phase: N/A
Study type: Interventional

This clinical trial aims to compare hepatectomy with Transarterial Chemoembolization (TACE) for Hepatic Cellular Cancer With Solitary Huge Tumor (≥5cm). All patients will be divided into two group.One group will receive hepatic resection, while an another equivalent group patients will be treated with Transarterial Chemoembolization.

NCT ID: NCT03052621 Completed - Survival Rate Clinical Trials

Revisiting Omental Transposition in Locally Advance and Locally Recurrent Breast Cancer

Start date: January 1994
Phase: N/A
Study type: Observational

Locally advance breast cancer and extensive locoregional recurrence are still considered as complexity of reconstruction. Although previous studies concluded that omental transposition was considerably indicated in poor vascularity in irradiated tissue, secondary infection and large defect become the obstacles of local tissue flaps. While some centres showed the excellent healing of omental transposition. Meanwhile, many studies showed the preferable outcome in escalating radiotherapy in term of locoregional control. In the investigators' institute, omental transposition in breast cancer has been developed for twenty years. The only institute in Thailand enhanced using this procedure in order to closure of large primary breast cancer and chest wall recurrence. This procedure is undertaken by single surgeon (Dr. K.J.). The investigators' protocol of omental transposition is including preoperative chemotherapy, preoperative accelerated radiation up to 80 Gy, approval of breast cancer centre committee, and meticulous wound care including vacuum assisted wound dressing, non-adhesive dressing. As a result, survival time could be improved.

NCT ID: NCT01905306 Active, not recruiting - Survival Rate Clinical Trials

Randomized Controlled Trial of Full-Arch Rehabilitation

Start date: January 2013
Phase: N/A
Study type: Interventional

This clinical study has the objective to compare the radiographic evaluations after 3 years of follow-up of immediate loaded implant-prosthetic rehabilitation, carried out randomly using the methodology for computer guided implant planning with software polyvalent or free hand implants placement.

NCT ID: NCT00949273 Recruiting - Rectal Cancer Clinical Trials

Safety and Efficacy Study of Cylindrical Abdominoperineal Resection to Treat Rectal Cancer

Start date: July 2009
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether cylindrical abdominoperineal resection is effective in the treatment of advanced very low rectal cancer

NCT ID: NCT00748358 Completed - Prostatic Neoplasms Clinical Trials

An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer

PROSUT
Start date: March 2008
Phase: Phase 2
Study type: Interventional

as second-line treatment in metastatic prostate cancer, the present study will investigate the efficacy of sunitinib (SUTENT) given orally at a dose of 37.5 mg continuously, for 6 cycles of 6 consecutive weeks .Patients who are still responders after 6 cycles will be treated until disease progression, pain progression, unacceptable toxicity or death due to any cause. Dose increase or reduction of 12.5 mg increments and change of schedule is recommended based on individual safety and tolerability. Follow-up for up to 1 year from the last dose of sunitinib.